Platelets and coagulation factors have diverse roles in many cardiovascular diseases, and basic and clinical research in this area has led to marked improvements in clinical outcomes, such as in patients with atherothrombotic events or atrial fibrillation. The pathways involved in thrombosis and haemostasis also play important roles in vascular inflammation and wound healing. The evolving complexities of the science and available treatments for management and prevention of thrombosis, as well as the requirements for yet more effective treatments, drive the need for ongoing dissemination of knowledge and development of consensus amongst both practising physicians and research scientists.
Mission
- Gather experts with different backgrounds to organise and drive scientific activities focused on the complex field of thrombosis and haemostasis
- Increase knowledge on the pathophysiological mechanisms as well as clinical data on thrombotic-related coronary events
Aims and Activities
- To enhance knowledge of thrombosis and stimulate basic research in haemostasis and thrombosis, to increase the current understanding on the pathophysiology, which is a necessary step to initiate the development of new preventive and therapeutic targets.
- To stimulate clinical research in haemostasis and thrombosis, with a special focus on young and talented investigators.
- To bridge basic science and clinical investigation with a translational and personalized perspective.
- To produce consensus documents and educational activities to form and support clinical practice in cardiology concerning drugs or treatments interfering with haemostasis and vascular biology
The Working Group on Thrombosis was established in the ‘60s, in the process of the general current shaping of the European Society of Cardiology. Constituent bodies of the Society are National Societies from various affiliated countries and Working Groups. These were intended, and still are, mostly, as the “scientific motor” of the Society, collecting active scientists in the cardiovascular area from whatever country in Europe around common themes.
The history of a Working Group on Thrombosis, one of the original Working Groups of the Society, is therefore a history of the interaction of persons from different origins, and often from quite different backgrounds, organising the scientific activities of the Society in this area of knowledge at the best of their intelligence and drive. At the beginning, this was mostly the Congress, but more and more, in recent years, the Working Group has expanded its scope through initiatives, many of which are ongoing, that continue far beyond the organisation of scientific sessions at the yearly venue.
